Clinical Trial Update: Study to Determine the Effect of an Anti-IgE Agent on Inflammatory Cells in the Skin of Atopic Dermatitis Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated the effect of an anti-IgE agent on inflammatory cells in the skin of patients with atopic dermatitis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Snippet

Sponsor: Medical University of Vienna | Conditions: Atopic Dermatitis | Phase 4 | Status: COMPLETED